(Q44196721)

30 November 2017

title

Effects of montelukast and budesonide on airway responses and airway inflammation in asthma (English)

1 reference

30 November 2017

1 reference

7

1 reference

30 November 2017

Richard Leigh

1

1 reference

30 November 2017

Dilini Vethanayagam

2

1 reference

30 November 2017

Makoto Yoshida

3

1 reference

30 November 2017

Richard M Watson

4

1 reference

30 November 2017

Tracy Rerecich

5

1 reference

30 November 2017

Mark D Inman

6

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

American Journal of Respiratory and Critical Care Medicine

30 November 2017

published in

1 reference

30 November 2017

volume

166

1 reference

30 November 2017

issue

9

1 reference

30 November 2017

page(s)

1212-1217

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200206-509OC

30 November 2017

1 reference

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200206-509OC

Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200206-509OC

Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200206-509OC

Dose-dependent effects of inhaled mometasone furoate on airway function and inflammation after allergen inhalation challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200206-509OC

Significant variability in response to inhaled corticosteroids for persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200206-509OC

Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200206-509OC

Treatment of asthma with drugs modifying the leukotriene pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200206-509OC

Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200206-509OC

Effect of oral prednisone on airway inflammatory mediators in atopic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200206-509OC

Effect of zafirlukast (Accolate) on cellular mediators of inflammation: bronchoalveolar lavage fluid findings after segmental antigen challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200206-509OC

A controlled trial of the effect of the 5-lipoxygenase inhibitor, zileuton, on lung inflammation produced by segmental antigen challenge in human beings

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200206-509OC

21 January 2018

Late asthmatic responses

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200206-509OC

Effect of methacholine challenge on cellular composition of sputum induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200206-509OC

Use of induced sputum cell counts to investigate airway inflammation in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200206-509OC

Reproducibility and comparison of responses to inhaled histamine and methacholine

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200206-509OC

Leukotriene D4 receptor blockade inhibits the immediate and late bronchoconstrictor responses to inhaled antigen in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200206-509OC

Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200206-509OC

Inhaled leukotriene E(4), but not leukotriene D(4), increased airway inflammatory cells in subjects with atopic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200206-509OC

Chronic cough: eosinophilic bronchitis without asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200206-509OC

Mast-cell infiltration of airway smooth muscle in asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200206-509OC

Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200206-509OC

Dysfunction and remodeling of the mouse airway persist after resolution of acute allergen-induced airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200206-509OC

Attenuation of early and late phase allergen-induced bronchoconstriction in asthmatic subjects by a 5-lipoxygenase activating protein antagonist, BAYx 1005

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200206-509OC

The trials and tribulations of IL-5, eosinophils, and allergic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200206-509OC

10.1164/RCCM.200206-509OC

21 January 2018

Identifiers

DOI

1 reference

30 November 2017

1 reference